Login
English
Nederlands
Nanomedicine and nanosafety
| Faculteit | Science and Engineering |
| Jaar | 2022/23 |
| Vakcode | WMFA047-05 |
| Vaknaam | Nanomedicine and nanosafety |
| Niveau(s) | master |
| Voertaal | Engels |
| Periode | semester I b |
| ECTS | 5 |
| Rooster | rooster.rug.nl |
| Uitgebreide vaknaam | Nanogeneeskunde (drug targeting, drug delivery, organ-on-a-chip) en nanoveiligheid | ||||||||
| Leerdoelen | At the end of the course, the student is able to 1. describe biological properties of nano-sized materials and their general behavior at cell and organism level in relation to both their applications in medicine (drug targeting, drug delivery, and organ-on-a-chip devices) and the potential risks of nanotechnologies (nanosafety) 2. analyze properties of nanomedicines in comparison to conventional drugs and compare characteristics of the main different classes of nanomedicines 3. identify challenges in different aspects of drug delivery and drug targeting and analyse solutions currently under investigation to address them, including challenges in synthesis of drug carriers and targeted drugs, modification of nanomedicine properties when applied in biological conditions, behavior of nanomedicines and other nanomaterials at cell and organism level (barriers to drug delivery) 4. evaluate literature on current challenges and latest developments in the different aspects mentioned in objectives 1-3 |
||||||||
| Omschrijving | This course covers the following topics: • nanomedicine for drug delivery and drug targeting • nanomedicine applications other than drug delivery and drug targeting (organ-on-a-chip devices, tissue regeneration, stem cell differentiation and assisted surgery) • overview of main classes of nanomedicines, such as lipid based drug carriers, polymer based drug carriers, inorganic nanoparticles, antibodies and immunoconjugates, bio-inspired nanocarriers • drug carriers and targeted drugs currently on the market and in clinical trials • challenges in nanomaterial design for successful targeting and barriers to drug delivery • methods to characterize nano-sized drug carriers after synthesis and once applied in biological environments (size, charge, stability in biological fluids such as blood) • behavior of nano-sized materials at cellular and and organism level (uptake, distribution, final fate, eventual effects on cellular functions) • potential risks and safety concerns for nanomedicines and nano-sized materials not intended to be in contact with humans and living organisms (other nanotechnologies). |
||||||||
| Uren per week | |||||||||
| Onderwijsvorm |
Bijeenkomst (S), Hoorcollege (LC), Opdracht (ASM), Werkcollege (T)
(Seminars: 12 hours; tutorials: 4 hours;) |
||||||||
| Toetsvorm |
Presentatie (P), Schriftelijk tentamen (WE)
(The assessment of group project is based on: -The scientific quality of the content (problem statement, 15% of project grade; literature quality and relevance, 20%) -Structure and layout of the slides (15%) -Verbal skills (10%) -Presentation behavior (5%) -Presentation of scientific content (15%) -Response to questions (20%). The MPS colloquium rubric has been adapted for this.) |
||||||||
| Vaksoort | master | ||||||||
| Coördinator | Prof. Dr. A. Salvati | ||||||||
| Docent(en) | Gastdocent(en) ,Prof. Dr. A. Salvati ,dr. P. van Rijn ,prof. dr. E.M.J. Verpoorte | ||||||||
| Verplichte literatuur |
|
||||||||
| Entreevoorwaarden | |||||||||
| Opmerkingen | There is a minimum of 10 students and a maximum of 30 students participating for course. Due to the limited capacity of the course, priority will be given to MSc students from Pharmacy and MPS. Adapted IU 24112022 |
||||||||
| Opgenomen in |